Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

​The wealth of this condom-making family has doubled in 2023

<ul><li>Income tax department is conducting searches at Mankind Pharma’s premises in Delhi, checking documents, and questioning people.</li><li>Mankind Pharma has been in the news since its <a href="https://www.businessinsider.in/stock-market/news/condom-maker-mankind-pharma-lists-at-20-premium-beats-grey-market-expectations/articleshow/100090002.cms">stellar debut on Tuesday </a>with 20% listing gains.</li><li>The company is known for products like MANforce condoms, Prega News pregnancy detection kits and Gas-o-Fast sachets.</li></ul>The Income Tax department on Thursday conducted searches on the premises of Mankind Pharma over allegations of tax evasion, official sources said. A PTI report said that searches are being conducted on the company premises in Delhi and nearby locations, documents are being checked and people are being questioned as part of the action launched early this morning. E-mail and queries sent by PTI to the company remained unanswered. Mankind Pharma recently went public, to raise ₹4,326 crore. The initial public offer was a complete offer for sale and its promoters received the proceeds from the share sale. Added to that, its <a href="https://www.businessinsider.in/stock-market/news/condom-maker-mankind-pharma-lists-at-20-premium-beats-grey-market-expectations/articleshow/100090002.cms">stock listed at a 22% premium</a> on May 9, and the company’s marketcap stands at ₹56,108 crore as of Thursday. The pharma company also entered the <a href="https://www.businessinsider.in/business/corporates/news/mankind-pharma-debuts-in-top-100-as-per-market-value-after-a-stellar-listing/articleshow/100123765.cms">top 100 companies club </a>on its debut day. On Thursday, it ranks at 90 in terms of largest listed companies in India, leaving behind the likes of Punjab National Bank, Hero MotoCorp, UPL, Indian Hotels and Zomato. Analysts say that the stock may continue to do well going ahead, backed by strong fundamentals. “Given its healthy financial track record, domestic focus and extensive network, Mankind is likely to continue doing well,” Hemang Jani, Head of Equity Strategy, Motilal Oswal Financial Services. “Moreover the healthcare sector was a laggard over the last one year but started seeing traction over the last two months as the monthly pharma data showed improvement,” added Jani. Macquarie Research has initiated coverage on the company with an ‘Outperform’ rating and a target price of ₹1,400. The brokerage believes that Mankind Pharma is at a discounted valuation than its peers — Abbott India, GSK India and Pfizer India. “We believe the company’s net profit could double (&gt;2x) in the next three years, driven by: a) continued sales outperformance relative to Indian pharma market (IPM), b) mix shift towards chronic therapies, and c) unlocking of meaningful operating leverage as salesforce productivity improves,” said the brokerage firm. The company’s stock has been falling after the listing day amid volatile market conditions. Today, the stock is down nearly 2% at 1,356. Incorporated in 1991, Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Its product portfolio includes MANforce condoms, Prega News pregnancy detection kits and Gas-o-Fast sachets. The company said that it’s looking to acquire brands and diversify its therapeutic portfolio to facilitate entry into new markets. (With inputs from PTI) SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/corporates/news/lt-q4-net-profit-rises-10-to-3987-crore-cautiously-optimistic-about-fy24/articleshow/100137513.cms">L&amp;T Q4 net profit rises 10% to ₹3,987 crore, cautiously optimistic about FY24</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/entertainment/news/ipl-2023-scores-over-1300-crore-video-views-on-jiocinema-in-the-first-five-weeks/articleshow/100155165.cms">IPL 2023 scores over 1,300 crore video views on JioCinema in the first five weeks</a>

Income Tax department raids freshly listed Mankind Pharma’s premises over alleged tax evasion

<keyword id="146847" type="General" weightage="20" keywordseo="Mankind-Pharma" source="Orion">Mankind Pharma</keyword> on Wednesday said it has inked a pact with Dr Reddy's Laboratories to acquire two brands -- <keyword id="13185092" type="General" weightage="80" keywordseo="combihale" source="Orion">Combihale</keyword> and <keyword id="13185091" type="General" weightage="80" keywordseo="daffy" source="Orion">Daffy</keyword>. While Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease, Daffy is a soap-free moisturising bar for infants. Mankind <keyword id="6363818" type="General" weightage="100" keywordseo="pharma" source="Orion">Pharma</keyword> said the market for Combihale is valued at Rs 900 crore growing at 14 per cent. The acquisition of the product is expected to strengthen the company's presence in the inhalation respiratory market segment, Mankind Pharma said in a statement. The total market for Daffy is valued at Rs 1,000 crore growing at 18 per cent, he added. "We believe these brands have adequate potential to grow in the Indian market and the best part of the acquisition is that both these brands perfectly fit in our portfolio, and provides us an opportunity to grow and build the respiratory and dermatology business further," Mankind Pharma President <keyword id="13185093" type="General" weightage="20" keywordseo="Atish-Majumdar" source="Orion">Atish Majumdar</keyword> noted. As per the terms of the definitive agreement executed between the companies, Mankind Pharma will take over the manufacturing, marketing and distribution of both the products in India. The entire integration and transition of the brands is expected to be completed by March 2022. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/check-out-top-10-stocks-that-minted-good-money-to-investors-when-the-whole-market-fell/slidelist/89612860.cms">10 stocks that minted good money for investors when the whole market was falling apart</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/science/space/news/virgin-galactic-opens-ticket-sales-for-space-tourism-flights/articleshow/89611012.cms">You can now purchase tickets to take a trip to space through Virgin Galactic’s space plane</a>

Mankind Pharma to acquire Dr Reddy's Laboratories's brand Combihale and Daffy

<ul><li>In India, brands are trying to figure out the right way to communicate with their audience during a national emergency and change their message, which makes marketing – and the role of CMO – more critical than ever.</li><li>In our latest interview series, we speak to a few CMOs to understand how they are helping out their organisations find the right ways to connect with consumers.</li><li>Today, we talk to Joy Chatterjee, General Manager of Sales and Marketing, <keyword id="146847" type="COMPANY" weightage="20" keywordseo="mankind-Pharma">Mankind Pharma</keyword> about how his role has changed during the second wave of COVID-19.</li></ul>As India continues to grapple with the second wave of the coronavirus pandemic, frontline workers are racing against time by fighting through the lack of supplies and increasing number of fatality rates to contain its spread. To extend its support during such testing times, Pharmaceutical giant Mankind Pharma has pivoted its <keyword id="489452" type="PERSON" weightage="20" keywordseo="marketing-strategy">marketing strategy</keyword> by using its advertising tools to spread awareness and spark more empathy towards our frontline workers. <div type="twitter" handle="Pharma_Mankind" handlename="Mankind Pharma" image="http://pbs.twimg.com/profile_images/922748683996688389/Ttocwphx_normal.jpg" favoritecount="52" retweetcount="5" status="- Lowers the risk of heart disease- Strengthens the immune system- Helps the body absorb iron- Prevents common c… https://t.co/tW2EKtOCQB" createdat="1621406840000" id="1394907505117908996"></div> <div type="twitter" handle="Pharma_Mankind" handlename="Mankind Pharma" image="http://pbs.twimg.com/profile_images/922748683996688389/Ttocwphx_normal.jpg" favoritecount="971" retweetcount="37" status="Lifestyle plays an important role in treating your high blood pressure, make sure to examine regularly and take con… https://t.co/hQ8XQPShto" createdat="1621239060000" id="1394203786600620032"></div> Telling us more about the company's larger marketing strategy now, Joy Chatterjee, General Manager of Sales and Marketing, Mankind Pharma said, “We are using our social media handles to put out the right knowledge and positive messages for the consumers. In the past few months, we have observed that people are tagging us to help them out the relevant information with regards to medicine, vaccination and others. We have ensured to extend our help, and are trying our best to respond to all the queries.” While COVID has been around for more than a year now and we are now used to working from home, this year feels nothing like 2020. Every social media post reminds us of the severity of the situation. At such a time, brands are trying to do their bit by donating, amplifying SoS requests on social media or volunteering. For Chatterjee, 2020 was a test match that helped him prepare for the storm and shift in the digital landscape. Now, he is trying to focus more on helping out his employees, finding a valid cause to associate with and come up with empathetic campaigns. “During the first phase of lockdown, we all witnessed numerous changes like the sudden shift to WFH, the two months imposed lockdown disrupted the supply chain. E-commerce business observed a tremendous response, as people relied on such apps for the delivery of products. However, in the second wave, all of us are more prepared and equipped for WFH and supply chain management. The situation related to lockdown vis-a-vis corona cases is different. The earlier experience has helped us on how to perform, and what sort of strategies should be implemented to avoid the hurdles,” said he. As an essential service provider, the major challenge for Mankind Pharma right now is to maintain its supply chain but it is focusing on digital mediums to reach out to a wider audience. Chatterjee shared, “There has been a lot of restriction due to lockdown in many states which is resulting in slow movement in our logistics. However, lockdown is necessary also to break the chain, and we strongly support the government. There is no doubt that the Pandemic has come with a shift in consumer preferences as well in terms of media consumption, people are spending a lot of time on digital media platforms and we are also focusing on such mediums. For instance, we choose mediums as per the demand, and right now we are highly focused on the digital medium to reach the target audience.” Mankind Pharma had launched a campaign three weeks ago with brand ambassador Anil Kapoor as a tribute to frontline warriors. It also contributed Rs 100 crore to families of Frontline martyred warriors and allocated Rs 40 crore from its CSR funds to help COVID patients and their families struggling for oxygen cylinders and concentrators. <div type="Youtube" id="_OTJk6aI06U" title="Mankind Pharma | 100 Crores tribute to the Frontline Warriors | Hindi" thumbUrl="https://i.ytimg.com/vi/_OTJk6aI06U/mqdefault.jpg"></div> This lockdown, a few Indian brands have put a pause on their advertising to give their consumers space to process or they have launched empathetic campaigns as a reminder of togetherness and better tomorrow. According to Chatterjee, if a brand is communicating during such times, he said that relevant and empathetic communication are the key areas that should be visible and adopted in the strategy. “Times are such, even if brands are not relevant to the Covid-19 situation, they have to show compassion and empathy to the unprecedented situation. Brands are apprehensive of not being compassionate and empathetic to the situation. Riding on a trend is important but it's always for short-term benefit, brands always try to explore different opportunities to communicate about their benefits keeping the core message universal,” elaborated Chatterjee. The second wave has pushed all leaders to prioritise their employees’ wellbeing and keep their business’ goals on hold. As a leader, Chatterjee’s focus areas have changed too. “Our employee wellbeing is our utmost priority,” said Chatterjee. “We have created a separate to-do list for employees to keep them safe which includes regular updates about their health, how to take precautions or preventive measures to keep themselves and family safe. We are keeping track of the vaccination, and we are making sure that all our employees get vaccinated. Mankind Pharma works on three core principles – People, product and seamless process in functioning the business across the company. In these hard-hitting times, we have ensured working remotely for everyone and have offered support to those in need to promote positive mental health amongst employees. Mankind Pharma has also increased the insured amount for medical urgencies.” However, Mankind Pharma’s revenue goals and growth targets remain the same. Chatterjee is optimistic that the company will continue to grow this year as per their plan. “Our numbers are still intact, and we are quite optimistic that the numbers will surpass this year due to our thoughtful preparation. There are no changes to our predefined goals,” said Chatterjee. According to IQVAI report, Mankind Pharma is the fourth largest pharmaceutical company in India. Indian pharma industry will have to grow at a CAGR of 12% to reach $130 billion by 2030 from $41.7 billion in 2020.

Even if brands are not relevant to the Covid-19 situation, they’ve to show compassion and empathy to the unprecedented situation: Joy Chatterjee, Mankind Pharma

<ul><li><keyword id="146847" type="PERSON" weightage="20" keywordseo="mankind-Pharma">Mankind Pharma</keyword> has launched a new ad starring <keyword id="26339" type="PERSON" weightage="20" keywordseo="Angad-Bedi">Angad Bedi</keyword>. </li><li>The company urges everyone to be a little more responsible and <keyword id="8352552" type="UNKNOWN" weightage="20" keywordseo="wear-a-mask">wear a mask</keyword> whenever we are stepping out.</li></ul>India is still grappling with the second wave of Covid-19 and continues to report over 1.5 lakh cases in a day. Mankind Pharma, the 4th largest pharmaceutical company in India has taken an initiative to aware all citizens about the importance of wearing a mask and urges them to do their bit with their new campaign #MaskMyIndia. Mankind Pharma has released a video that captures the stories of our heroes, who are setting examples and doing more than their call of duty during the COVID-19 pandemic in India. The campaign, #MaskMyIndia brings together the current working hours and situations of our doctors and walks the audience through the overall working routine and how each one of them is working day and night to ensure everyone is safe. Despite all the efforts our frontline workers are putting, the mortality rate is on the higher side and everyone is witnessing the grief of losing their loved ones. Through this campaign Mankind Pharma urges everyone to do their bit by wearing a mask properly and help them to fight the deadly virus. They are requesting each one of us to be responsible citizens and not take this situation lightly. Not wearing a mask is not an option and we all should ensure we support our frontline workers by just doing the basics. <div type="Youtube" id="XILcRM9YCsA" title="Leave excuses, Be responsible | Mask My India | Angad Bedi | Hindi" thumbUrl="https://i.ytimg.com/vi/XILcRM9YCsA/mqdefault.jpg"></div> The campaign is designed to raise awareness and to grow a sense of responsibility amongst the audience and encourages all of us to take a pledge to wear a mask correctly, that is by covering nose and mouth entirely. Commenting on the campaign Rajeev Juneja, Managing Director &amp; Vice Chairman, Mankind Pharma, said “At Mankind Pharma, we follow a strong brand philosophy of raising awareness on social issues. Through this campaign, we would like to spread the message that together we can all fight with deadly coronavirus, all we have to do is wear a mask and follow all the preventive measures given by the government. The video campaign is an attempt by Mankind Pharma to deliver the message of Wearing a Mask, and keep ourselves and our loved ones safe and healthy. We all need to behave as responsible citizens and take ownership of ensuring our safety and other’s as well.” During this pandemic, we strongly recommend wearing a mask. Let’s pledge not to venture out without wearing masks so that we can fight coronavirus and come out as a winner from this pandemic.

Mankind Pharma urges citizens to stop giving excuses for not wearing a mask in its latest campaign

<ul><li>Actor <keyword id="6354625" type="General" weightage="80" keywordseo="vijay-sethupathi" source="Orion">Vijay Sethupathi</keyword> has been roped in as the brand ambassador of Mankid Pharma.</li><li>As a part of the association, <keyword id="146847" type="General" weightage="80" keywordseo="mankind-pharma" source="Orion">Mankind Pharma</keyword> will donate Rs 31 lakh to the Film Employees Federation of South India (FEFSI).</li></ul>Pharmaceutical company <keyword id="111790" type="General" weightage="100" keywordseo="mankind" source="Orion">Mankind</keyword> Pharma has announced its association with Vijay Sethupathi, an Indian actor and producer who predominantly has contributed in the Tamil cinema. In lieu of this association, Mankind Pharma, the company will be donating an amount of Rs 31 lakh to the Film Employees Federation of South India (FEFSI). FEFSI is an Indian organisation consisting of technicians from the <keyword id="6412552" type="General" weightage="20" keywordseo="tamil-film-industry" source="Orion">Tamil Film Industry</keyword> in Tamil Nadu, India. The amount donated will help all those who are facing a slowdown due to the pandemic and will support the growth of the organization and its members. Vijay Sethupathi has won 15 awards in the category of Best Actor which includes Filmfare Award- Tamil, <keyword id="128899" type="General" weightage="20" keywordseo="national-film-award" source="Orion">National Film Award</keyword>, <keyword id="12247905" type="General" weightage="20" keywordseo="vijay-award" source="Orion">Vijay Award</keyword> for Best actor and many more. Speaking on the partnership, Sethupathi said, “It is a pleasure to partner with Mankind Pharma as the brand ambassador and represent the brand in the southern market. The company perfectly justifies the true meaning of ‘Mankind’ and the motto of ‘Serving Life’ in the industry. I am honoured to be a part of the Mankind Pharma family and hope to serve the society together.” Speaking on the occasion, <keyword id="4921166" type="General" weightage="20" keywordseo="Rajeev-Juneja" source="Orion">Rajeev Juneja</keyword>, Managing Director and Vice Chairman, Mankind Pharma said, “We believe that Vijay Sethupathi is an ideal personality for us as a brand ambassador and has an emotional connect with the audience which is why people call him “People’s Treasure”. Both Mankind Pharma and the superstar have a common synergy and thought process of serving life in the country, and we feel this mutual alliance will be a prolific one for both of us. We at Mankind Pharma always selflessly contribute towards the betterment of the society and believe in serving life, we hope that the token amount donated to FEFSI will help provide assurance towards the growth of the company. Together we will continue to selflessly contribute towards the betterment of the society.” Mankind Pharma aspires to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs.

You Searched For "Mankind Pharma" and got 6 results

The wealth of this condom-making family has doubled in 2023

Katya Naidu

Income Tax department raids freshly listed Mankind Pharma’s premises over alleged tax evasion

Bhakti Makwana

Mankind Pharma to acquire Dr Reddy's Laboratories's brand Combihale and Daffy

PTI

Even if brands are not relevant to the Covid-19 situation, they’ve to show compassion and empathy to the unprecedented situation: Joy Chatterjee, Mankind Pharma

Karuna Sharma

Mankind Pharma urges citizens to stop giving excuses for not wearing a mask in its latest campaign

BI India Partner

Mankind Pharma ropes in Vijay Sethupathi as its brand ambassador

BI India Partner

Popular Keywords

Buying Guides

You Searched For "Mankind Pharma" and got 6 results

​The wealth of this condom-making family has doubled in 2023

Katya Naidu

Income Tax department raids freshly listed Mankind Pharma’s premises over alleged tax evasion

Bhakti Makwana

Mankind Pharma to acquire Dr Reddy's Laboratories's brand Combihale and Daffy

PTI

Even if brands are not relevant to the Covid-19 situation, they’ve to show compassion and empathy to the unprecedented situation: Joy Chatterjee, Mankind Pharma

Karuna Sharma

Mankind Pharma urges citizens to stop giving excuses for not wearing a mask in its latest campaign

BI India Partner

Mankind Pharma ropes in Vijay Sethupathi as its brand ambassador

BI India Partner

Popular Keywords

Buying Guides

The wealth of this condom-making family has doubled in 2023